188. Deputy David Cullinane asked the Minister for Health the contingency plan and guidance in place and issued by the HSE in response to the shortages of certain salbutamol products; the list of salbutamol products which are approved for reimbursement; whether each of these is in stock; the availability of substitute products for which a reimbursement price has not been agreed but which have been identified as an approved substitute during a shortage of reimbursable products; if during shortages, there is a mechanism for patients to access products outside of the list of reimbursable products where they have a clinical and economic need; and if she will make a statement on the matter. [6711/26]

Summary

188. Deputy David Cullinane asked the Minister for Health the contingency plan and guidance in place and issued by the HSE in response to the shortages of certain salbutamol products; the list of salbutamol products which are approved for reimbursement; whether each of these is in stock; the availability of substitute products for which a reimbursement price has not been agreed but which have been identified as an approved substitute during a shortage of reimbursable products; if during shortages, there is a mechanism for patients to access products outside of the list of reimbursable products where they have a clinical and economic need; and if she will make a statement on the matter. [6711/26]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 28 January 2026

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.